Non-Operating Income/Expense (Annual)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

MiniMed Group, Inc. (MMED) had Non-Operating Income/Expense of -1.00M for the most recently reported fiscal year, ending 2026-04-30.

Quarterly Annual

Figures for fiscal year ending 2026-04-30

Income Statement Financials
Revenue	3.10B
Net Income	-333.00M
Cost of Goods Sold	1.42B
Gross Profit	1.68B
Operating Expenses	3.29B
Operating Income	-190.00M
Non-Operating Income/Expense	-1.00M
Pre-Tax Income	-189.00M
Normalized Pre-Tax Income	-189.00M
Income after Taxes	-317.00M
Income from Continuous Operations	-317.00M
Consolidated Net Income/Loss	-317.00M
Normalized Income after Taxes	-317.00M
EBIT	-190.00M
EBITDA	-34.00M
Weighted-Average Shares Outstanding (Basic)	256.60M
Weighted-Average Shares Outstanding (Diluted)	256.60M
Earnings per Share (EPS) (Basic)	-1.30
Earnings per Share (EPS) (Diluted)	-1.30
Balance Sheet Financials
Current Assets	1.35B
Property, Plant, and Equipment	711.00M
Long-Term Assets	3.28B
Total Assets	4.63B
Current Liabilities	702.00M
Long-Term Debt	--
Long-Term Liabilities	317.00M
Total Liabilities	1.02B
Common Equity	3.61B
Tangible Shareholders Equity	1.25B
Shareholders Equity	3.61B
Common Shares Outstanding	280.82M
Cash Flow Statement Financials
Cash Flow from Operating Activities	-197.00M
Cash Flow from Investing Activities	-233.00M
Cash Flow from Financial Activities	716.00M
Beginning Cash	11.00M
End Cash	298.00M
Increase/Decrease in Cash	287.00M
Stock-Based Compensation	46.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	54.16%
Operating Margin	-6.13%
EBIT Margin	-6.13%
EBITDA Margin	-1.10%
Pre-Tax Profit Margin	-6.09%
Profit Margin	-10.73%
Free Cash Flow	-420.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.67
Inventory Turnover	4.17
Receiveable Turnover	15.51
Days Sales in Receivables	23.53
Return on Equity	-8.78%
Return on Tangible Equity	-25.40%
Return on Assets	-6.85%
Return on Investments	-8.78%
Book Value Per Share	12.86
Free Cash Flow per Share	-1.64
Operating Cash Flow per Share	-0.77

Data from Zacks Investment Research, Inc.